The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases
Pharmaceutics · 21.03.2023 · 15 (3) · 1006
DOI: 10.3390/pharmaceutics15031006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 21.03.2023. Verfasst von Amin Iranpanah und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran. Die Arbeit wurde bisher 66-mal zitiert (Crossref) und nennt 117 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Student Research Committee at the Kermanshah University of Medical Sciences, Kermanshah, Iran.
Abstract (Originalsprache)
As major public health concerns associated with a rapidly growing aging population, neurodegenerative diseases (NDDs) and neurological diseases are important causes of disability and mortality. Neurological diseases affect millions of people worldwide. Recent studies have indicated that apoptosis, inflammation, and oxidative stress are the main players of NDDs and have critical roles in neurodegenerative processes. During the aforementioned inflammatory/apoptotic/oxidative stress procedures, the phosphoinositide 3-kinase (PI3K)/protein kinase B (Akt)/mammalian target of rapamycin (mTOR) pathway plays a crucial role. Considering the functional and structural aspects of the blood–brain barrier, drug delivery to the central nervous system is relatively challenging. Exosomes are nanoscale membrane-bound carriers that can be secreted by cells and carry several cargoes, including proteins, nucleic acids, lipids, and metabolites. Exosomes significantly take part in the intercellular communications due to their specific features including low immunogenicity, flexibility, and great tissue/cell penetration capabilities. Due to their ability to cross the blood–brain barrier, these nano-sized structures have been introduced as proper vehicles for central nervous system drug delivery by multiple studies. In the present systematic review, we highlight the potential therapeutic effects of exosomes in the context of NDDs and neurological diseases by targeting the PI3K/Akt/mTOR signaling pathway.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pharmaceutical Sciences Research Center, Health Institute, Kermanshah University of Medical Sciences, Kermanshah 6734667149, Iran.
- USERN Office, Kermanshah University of Medical Sciences, Kermanshah 6715847141, Iran.
- Student Research Committee, Kermanshah University of Medical Sciences, Kermanshah 6714415153, Iran.
- Department of Physiology and Pharmacology "Vittorio Erspamer", Sapienza University, P.le Aldo Moro 5, 00185 Rome, Italy.
- Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
ORCID-Profile: Seyed Zachariah Moradi, Luciano Saso, Sajad Fakhri, Haroon Khan
Förderung
- Student Research Committee at the Kermanshah University of Medical Sciences, Kermanshah, Iran
Zitieren
APA
Iranpanah, A., Kooshki, L., Moradi, S. Z., Saso, L., Fakhri, S., & Khan, H. (2023). The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases. Pharmaceutics, 15(3), 1006. https://doi.org/10.3390/pharmaceutics15031006
Vancouver
Iranpanah A, Kooshki L, Moradi SZ, Saso L, Fakhri S, Khan H. The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases. Pharmaceutics. 2023;15(3):1006. doi:10.3390/pharmaceutics15031006
BibTeX
@article{Iranpanah2023,
author = {Iranpanah, Amin and Kooshki, Leila and Moradi, Seyed Zachariah and Saso, Luciano and Fakhri, Sajad and Khan, Haroon},
title = {The Exosome-Mediated PI3K/Akt/mTOR Signaling Pathway in Neurological Diseases},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {3},
pages = {1006},
doi = {10.3390/pharmaceutics15031006}
}
EUVIMED